PAIM
APTO

Punch & Associates Investment Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Punch & Associates Investment Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1
Closed -$1.01K – 247
2015
Q4 		$1.01K Buy
+1
New +$1.77K ﹤0.01% 266

Other funds holding APTO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Punch & Associates Investment Management's APTO Position: Q1 2016 in Review

Punch & Associates Investment Management sold out of Aptose Biosciences, Inc. (APTO) in Q1 2016, closing a stake of 1 share — an estimated $1.01K sold.

Punch & Associates Investment Management first reported a position in APTO in Q4 2015 and held it in 1 quarter. The position peaked at $1.01K in Q4 2015. 11 funds tracked by Wall St. Rank hold APTO as of Q1 2016.

  • Punch & Associates Investment Management reported no remaining Aptose Biosciences, Inc. position as of Q1 2016 after selling out during the quarter.
  • Punch & Associates Investment Management sold 1 Aptose Biosciences, Inc. share in Q1 2016, an estimated $1.01K.
  • Punch & Associates Investment Management first reported a position in Aptose Biosciences, Inc. in Q4 2015 and held it in 1 quarter.
  • Punch & Associates Investment Management's Aptose Biosciences, Inc. position peaked at $1.01K in Q4 2015.
  • 11 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2016.

Based on Punch & Associates Investment Management's 13F filing for Q1 2016, filed 25 Apr 2016.